Regulasi Artemisin melalui Jalur CYP11A1 dan LONP1 dalam Mengobati Polycystic Ovarii Syndrome (PCOS) - Related Insulin Resistance
DOI:
https://doi.org/10.31539/908h0k04Abstract
This study aims to analyze the therapeutic potential of Artemisia annua L. derivatives, specifically artemisinin, in modulating disrupted endocrine and metabolic pathways in PCOS. This research method utilized a literature review, with data sources consisting of journal articles and books related to the research topic. The results indicate that the pharmacological properties of artemisinin can treat PCOS-related insulin resistance through its regulatory interaction with the CYP11A1 and LONP1 pathways. Artemisinin can also enhance CYP11A1 degradation by directly binding to the mitochondrial protease LONP1, reducing androgen synthesis and alleviating insulin resistance. By targeting steroidogenesis and mitochondrial function, artemisinin emerges as a promising multi-target alternative therapy for PCOS with fewer side effects. In conclusion, artemisinin shows good molecular and clinical potential for overcoming insulin resistance in PCOS patients.
Keywords: Artemisinin, CYP11A1, LONP1, PCOS, Insulin Resistance
References
Boegl, M., Dewailly, D., Marculescu, R., Steininger, J., Ott, J., & Hager, M. (2024). The LH: FSH Ratio in Functional Hypothalamic Amenorrhea: An Observational Study. Jorna. of Clinical Medicine., 13(5), 1201. https://doi.org/10.3390/jcm13051201
Cai, M., Ni, Z., Yuan, Z., Yu, J., Zhang, D., Yao, R., Zhou, L., & Yu, C. (2023). Past and Present: A Bibliometric Study on Polycystic Ovary Syndrome. Journal of Ovarian Research, 16, 1–12. https://doi.org/10.1186/s13048-022-01072-3
Carmina, E., & Longo, R. A. (2023). Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs. Journal of Clinical Medicine, 12(18). https://doi.org/10.3390/jcm12185921
Fan, H., Ren, Q., Sheng, Z., Deng, G., & Li, L. (2023). The Role of the Thyroid in Polycystic Ovary Syndrome. Frontiers in Endocrinology, 14, 1–12. https://doi.org/10.3389/fendo.2023.1242050
Genazzani, A. D., & Genazzani, A. R. (2023). Polycystic Ovary Syndrome As Metabolic Disease: New Insights on Insulin Resistance. TouchREVIEWS in Endocrinology, 19(1), 71–77. https://doi.org/10.17925/EE.2023.19.1.71
Giménez-Peralta, I., Lilue, M., Mendoza, N., Tesarik, J., & Mazheika, M. (2022). Application of a New Ultrasound Criterion For the Diagnosis of Polycystic Ovary Syndrome. Frontiers in Endocrinology, 13, 1–7. https://doi.org/10.3389/fendo.2022.915245
Gyliene, A., Straksyte, V., & Zaboriene, I. (2022). Value of Ultrasonography Parameters in Diagnosing Polycystic Ovary Syndrome. Open Medicine (Poland), 17(1), 1114–1122. https://doi.org/10.1515/med-2022-0505
Hajam, Y. A., Rather, H. A., Neelam, Kumar, R., Basheer, M., & Reshi, M. S. (2024). A Review on Critical Appraisal and Pathogenesis of Polycystic Ovarian Syndrome. Endocrine and Metabolic Science, 14, 100162. https://doi.org/10.1016/j.endmts.2024.100162
Houston, E. J., & Templeman, N. M. (2025). Reappraising the Relationship between Hyperinsulinemia and Insulin Resistance in PCOS. Journal of Endocrinology, 265(2), 1–62. https://doi.org/10.1530/JOE-24-0269
Janu, J., & Mardhiyani, D. (2025). Kontribusi Kegemukan dan Resistensi Insulin dalam Perkembangan Sindrom Ovarium Polikistik: Suatu Kajian Pustaka. Jurnal Mahasiswa Ilmu Kesehatan, 3(2), 248–262. https://doi.org/10.59841/jumkes.v3i2.2581
Kentistou, K. A., Kaisinger, L. R., Stankovic, S., Vaudel, M., Mendes de Oliveira, E., Messina, A., Walters, R. G., Liu, X., Busch, A. S., Helgason, H., Thompson, D. J., Santoni, F., Petricek, K. M., Zouaghi, Y., Huang-Doran, I., Gudbjartsson, D. F., Bratland, E., Lin, K., Gardner, E. J., … Winqvis, R. (2024). Understanding the Genetic Complexity of Puberty Timing Across the Allele Frequency Spectrum. Nature Genetics, 56(7), 1397–1411. https://doi.org/10.1038/s41588-024-01798-4
Kostroun, K. E., Goldrick, K., Mondshine, J. N., Robinson, R. D., Mankus, E., Reddy, S., Wang, Z., Song, X., & Knudtson, J. F. (2023). Impact of Updated International Diagnostic Criteria for the Diagnosis of Polycystic Ovary Syndrome. F and S Reports, 4(2), 173–178. https://doi.org/10.1016/j.xfre.2022.12.003
Ligocka, N., Chmaj-Wierzchowska, K., Wszołek, K., Wilczak, M., & Tomczyk, K. (2024). Quality of Life of Women with Polycystic Ovary Syndrome. Medicina (Lithuania), 60(2). https://doi.org/10.3390/medicina60020294
Liu, Y., Jiang, J., Du, S., Mu, L. S., Fan, J., Hu, J., Ye, Y., Ding, M., Zhou, W., Yu, Q., Xia, Y., Xu, H., Shi, Y., Qian, S., Tang, Y., Li, W., Dang, Y., Dong, X., Li, X., Xu, C., & Tang, Q. (2024). Artemisinins Ameliorate Polycystic Ovarian Syndrome By Mediating LONP1-CYP11A1 Interaction. Science, 384(6701), eadk5382. https://doi.org/10.1126/science.adk5382
Melin, J. M., Forslund, M., Alesi, S. J., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A. S., Witchel, S. F., Mousa, A., & Teede, H. J. (2024). Effects of Different Insulin Sensitisers in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Clinical Endocrinology, 100(2), 149–163. https://doi.org/10.1111/cen.14983
Mosorin, M. E., Piltonen, T., Rantala, A. S., Kangasniemi, M., Korhonen, E., Bloigu, R., Tapanainen, J. S., & Morin-Papunen, L. (2023). Oral and Vaginal Hormonal Contraceptives Induce Similar Unfavorable Metabolic Effects in Women with PCOS: A Randomized Controlled Trial. Journal of Clinical Medicine, 12(8). https://doi.org/10.3390/jcm12082827
Na, Z., Jiang, H., Meng, Y., Song, J., Feng, D., Fang, Y., Shi, B., & Li, D. (2022). Association of Galactose and Insulin Resistance in Polycystic Ovary Syndrome: A Case-Control Study. EClinicalMedicine, 47, 1–11. https://doi.org/10.1016/j.eclinm.2022.101379
Noguchi, H., Iwasa, T., Iwase, A., Kanasaki, H., Kimura, F., Kugu, K., Saito, K., Baba, T., Hara, T., & Matsuzaki, T. (2024). Cut-off Value for Anti-Müllerian Hormone in the Diagnostic Criteria for Polycystic Ovary Syndrome in the Japanese Population. Journal of Obstetrics and Gynaecology Research, 50(8), 1368–1382. https://doi.org/10.1111/jog.15972
Nurdianto, A. R., Harnanik, T., & Setiawan, F. (2024). Pendekatan Terapi Hyperbaric Oxygen Therapy pada Pasien dengan Polycystic Ovary Syndrome. Calvaria Medical Journal, 2(2), 166–175. https://doi.org/10.30742/cmj.v2i2.168
Salsabila, W. Q., Adyani, K., & Realita, F. (2024). Literatur Review: Faktor Resiko Sindrom Ovarium Polikistik pada Remaja. Journal of Health (JoH), 11(02), 164–174. https://doi.org/10.30590/joh.v11n2.832
Su, P., Chen, C., & Sun, Y. (2025). Physiopathology of Polycystic Ovary Syndrome in Endocrinology, Metabolism and Inflammation. Journal of Ovarian Research , 18(1). https://doi.org/10.1186/s13048-025-01621-6
Tavares, W. R., Seca, A. M. L., & Barreto, M. C. (2025). Exploring the Therapeutic Potential of Artemisia and Salvia Genera in Cancer, Diabetes, and Cardiovascular Diseases: A Short Review of Clinical Evidence. Journal of Clinical Medicine, 14(3), 1–32. https://doi.org/10.3390/jcm14031028
Wahyuni, A., Supriyatiningsih, S., Kusumawati, W., Kirana, K. S., & Mayayustika, C. D. (2022). Family history of PCOS, Obesity, Low Fiber Diet, and Low Physical Activity Increase The Risk of PCOS. Jurnal Kedokteran dan Kesehatan Indonesia, 13(1). https://doi.org/10.20885/jkki.vol13.iss1.art8
Wang, L., Luo, M., Yu, X., Li, R., Ye, F., Xiong, D., Gong, Y., Zheng, M., Liu, W., & Zeng, J. (2024). Assessing the Clinical Diagnostic Value of Anti-Müllerian Hormone in Polycystic Ovarian Syndrome and its Correlation with Clinical and Metabolism Indicators. Journal of Ovarian Research, 17, 1–10. https://doi.org/10.1186/s13048-024-01405-4
Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023). Insulin Resistance in Polycystic Ovary Syndrome Across Various Tissues: An Updated Review of Pathogenesis, Evaluation, and Treatment. Journal of Ovarian Research, 16, 1–17. https://doi.org/10.1186/s13048-022-01091-0
Zhou, K., Lou, C., Chang, P., Jiang, J., Zhao, Y., Chang, H., & Mu, L. (2025). Promising Drugs For PCOS: Targeting Metabolic and Endocrine Dysfunctions. Nature Reviews Endocrinology, 21, 455-456. https://doi.org/10.1038/s41574-025-01121-z
Zhu, T., & Goodarzi, M. O. (2022). Causes and Consequences of Polycystic Ovary Syndrome: Insights from Mendelian Randomization. Journal of Clinical Endocrinology and Metabolism, 107(3), E899–E911. https://doi.org/10.1210/clinem/dgab757
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhammad Dary Margolang, Nurul Hidayah, Fairuz Alifia Aksalansia Hudawi, Fara Nayo Faramarisa, Yusa Amin Nurhuda
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
